Bonesupport has new face of Global Marketing & Communications

Annelie Aava Vikner has been appointed to Executive Vice President of Global Marketing & Communications

Swedish-based Bonesupport has appointed Vikner as the new addition to the leadership team. The orthobiologics company has created this new position to cover responsibilities formerly the duty of the Chief Marketing Officer(CMO). The former CMO, Linda Butcher, has now taken on the role of Vice President of Training and Events.

Vikner has 15 years of experience in marketing management roles for the Irish-based Medtronic. Her latest role was Senior Strategy and Marketing manager across many European countries.

Emil Billbäck, Bonesupport CEO, said: “Annelie Aava Vikner will be an important addition to the Bonesupport leadership team. Her experience will be of value for the exciting time ahead of us. Additionally, I want to thank Linda Butcher for her achievements as Chief Marketing Officer.”

You may also like

Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Regulatory

Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China

The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
Manufacturing

Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company

The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
Regulatory

Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval

The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia
Research & Development

Transmission Raman Spectroscopy - access the webinar series today

Offering significant advantages for bulk, quantitative and non-destructive analysis, Transmission Raman Spectroscopy is a preferred choice for applications where surface analysis is insufficient or prone to errors. Speakers from Agilent, Novartis Pharma, AstraZeneca, Bristol-Myers Squibb and AbbVie go deeper in this FREE webinar series
Subscribe now